<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03660618</url>
  </required_header>
  <id_info>
    <org_study_id>201702725</org_study_id>
    <nct_id>NCT03660618</nct_id>
  </id_info>
  <brief_title>LSFG-SKIN, Laser Speckle Flowgraphy</brief_title>
  <official_title>LSFG-SKIN, Laser Speckle Flowgraphy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Iowa</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Iowa</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this project is to quantify normal and abnormal skin blood flow regionally in&#xD;
      different areas of the body(face, extremities, over burns and wounds) at baseline and over&#xD;
      time in response to treatment or environmental changes, such as temperature, light and&#xD;
      pressure.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Laser speckle skin blood flow (LSFG-SKIN) will be recorded in normal subjects and in patients&#xD;
      with disorders affecting skin capillary perfusion, which may include cardiovascular&#xD;
      disorders, dermatologic disorders, skin wounds, ocular disorders, psychiatric disorders, and&#xD;
      neurologic disorders.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">May 23, 2017</start_date>
  <completion_date type="Actual">March 2, 2018</completion_date>
  <primary_completion_date type="Actual">March 2, 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Laser Speckle Skin Blood Flow</measure>
    <time_frame>30 minutes</time_frame>
    <description>explore how spatial and temporal variations in skin blood flow reveal the status of stated systems.</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">100</enrollment>
  <condition>Hypertension</condition>
  <condition>Heart Failure</condition>
  <condition>Vascular Ischemia</condition>
  <condition>Burns</condition>
  <condition>Chemotherapy Effect</condition>
  <condition>Radiation Injuries</condition>
  <condition>Uveitis</condition>
  <condition>Scleritis</condition>
  <condition>Multiple Sclerosis</condition>
  <condition>Autonomic Neuropathy</condition>
  <condition>Stroke</condition>
  <condition>Intracranial Hemorrhages</condition>
  <condition>TIA</condition>
  <condition>Migraine</condition>
  <condition>Headache</condition>
  <condition>Pain</condition>
  <arm_group>
    <arm_group_label>Clinic Subjects</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>cardiology subjects, dermatology subjects, endocrine subjects, neurology subjects, psychiatry subjects, surgery subjects, ophthalmology subjects.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>laser speckle flowgraphy</intervention_name>
    <description>blood flow state of the skin as real time two dimensional image</description>
    <arm_group_label>Clinic Subjects</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
        Controls&#xD;
&#xD;
        ‚óèHealthy normal control subjects ages 18-90&#xD;
&#xD;
        Cardiology Subjects&#xD;
&#xD;
          -  Ages 18-90&#xD;
&#xD;
          -  History of dysrhythmia, heart failure, cardiac ischemia, hypertension, peripheral&#xD;
             vascular disease&#xD;
&#xD;
        Dermatology Subjects&#xD;
&#xD;
          -  Ages 18-90&#xD;
&#xD;
          -  History of inflammatory and cancerous lesions&#xD;
&#xD;
        Endocrine Subjects&#xD;
&#xD;
          -  Ages 18-90&#xD;
&#xD;
          -  History of diabetes, thyroid disease&#xD;
&#xD;
        Neurology Subjects&#xD;
&#xD;
          -  Ages 18-90&#xD;
&#xD;
          -  History of dementia, headaches, Parkinson's, light sensitivity, stroke, TIA, multiple&#xD;
             sclerosis&#xD;
&#xD;
        Psychiatry Subjects&#xD;
&#xD;
          -  Ages 18-90&#xD;
&#xD;
          -  History of bipolar, schizophrenia, anxiety, depression&#xD;
&#xD;
        Surgery Subjects&#xD;
&#xD;
          -  Ages 18-90&#xD;
&#xD;
          -  History of skin wounds(trauma, chemotherapy, radiation), thermal burns, or plastic and&#xD;
             reconstructive surgical procedures.&#xD;
&#xD;
        Ophthalmology Subjects&#xD;
&#xD;
          -  Ages 18-90&#xD;
&#xD;
          -  History of ocular disorders caused by hypo perfusion or inflammatory disorders&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
        Controls&#xD;
&#xD;
          -  Cataract or media opacity that would degrade the imaging of the retina. Mild cataracts&#xD;
             are okay.&#xD;
&#xD;
          -  Angle closure glaucoma&#xD;
&#xD;
        Cardiology Subjects&#xD;
&#xD;
          -  Cataract or media opacity that would degrade the imaging of the retina. Mild cataracts&#xD;
             are okay.&#xD;
&#xD;
          -  Angle closure glaucoma&#xD;
&#xD;
             3. Dermatology Subjects&#xD;
&#xD;
          -  Cataract or media opacity that would degrade the imaging of the retina. Mild cataracts&#xD;
             are okay.&#xD;
&#xD;
          -  Angle closure glaucoma&#xD;
&#xD;
        Endocrine Subjects&#xD;
&#xD;
          -  Cataract or media opacity that would degrade the imaging of the retina. Mild cataracts&#xD;
             are okay.&#xD;
&#xD;
          -  Angle closure glaucoma&#xD;
&#xD;
        Neurology Subjects&#xD;
&#xD;
          -  Cataract or media opacity that would degrade the imaging of the retina. Mild cataracts&#xD;
             are okay.&#xD;
&#xD;
          -  Angle closure glaucoma&#xD;
&#xD;
        Psychiatry Subjects&#xD;
&#xD;
          -  Cataract or media opacity that would degrade the imaging of the retina. Mild cataracts&#xD;
             are okay.&#xD;
&#xD;
          -  Angle closure glaucoma&#xD;
&#xD;
        Surgery Subjects&#xD;
&#xD;
          -  Cataract or media opacity that would degrade the imaging of the retina. Mild cataracts&#xD;
             are okay.&#xD;
&#xD;
          -  Angle closure glaucoma&#xD;
&#xD;
        Ophthalmology Subjects&#xD;
&#xD;
          -  Cataract or media opacity that would degrade the imaging of the retina. Mild cataracts&#xD;
             are okay.&#xD;
&#xD;
          -  Angle closure glaucoma&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>University of Iowa Department of Ophthalmology</name>
      <address>
        <city>Iowa City</city>
        <state>Iowa</state>
        <zip>52242</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>September 2018</verification_date>
  <study_first_submitted>July 12, 2018</study_first_submitted>
  <study_first_submitted_qc>September 4, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">September 6, 2018</study_first_posted>
  <last_update_submitted>September 5, 2018</last_update_submitted>
  <last_update_submitted_qc>September 5, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">September 7, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Iowa</investigator_affiliation>
    <investigator_full_name>Randy Kardon</investigator_full_name>
    <investigator_title>Randy Kardon M.D. Ph.D Professor and Director of Neuro-ophthalmology</investigator_title>
  </responsible_party>
  <keyword>perfusion</keyword>
  <keyword>inflammatory</keyword>
  <keyword>ischemia</keyword>
  <keyword>lesions</keyword>
  <keyword>neuropathy</keyword>
  <keyword>burns</keyword>
  <keyword>cancer</keyword>
  <keyword>stroke</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Multiple Sclerosis</mesh_term>
    <mesh_term>Intracranial Hemorrhages</mesh_term>
    <mesh_term>Uveitis</mesh_term>
    <mesh_term>Scleritis</mesh_term>
    <mesh_term>Hemorrhage</mesh_term>
    <mesh_term>Ischemia</mesh_term>
    <mesh_term>Headache</mesh_term>
    <mesh_term>Radiation Injuries</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <pending_results>
    <submitted>May 7, 2019</submitted>
    <returned>May 28, 2019</returned>
    <submitted>April 26, 2021</submitted>
    <submission_canceled>May 4, 2021</submission_canceled>
    <submitted>May 4, 2021</submitted>
    <returned>May 26, 2021</returned>
    <submitted>May 28, 2021</submitted>
    <returned>June 21, 2021</returned>
    <submitted>June 24, 2021</submitted>
    <returned>July 14, 2021</returned>
  </pending_results>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

